Myasthenia Gravis Studies

Research Studies for Myasthenia Gravis

Are you living with Myasthenia Gravis (MG)?

The RemeMG study is testing a study drug called telitacicept to see how safe and effective it might be in adults living with generalized MG.
You may be eligible to join if you:
  • Are 18 years or older
  • Have been diagnosed with gMG
  • Do not have any other autoimmune diseases, like rheumatoid arthritis or Sjogren’s syndrome
If you qualify, you will have a 50% chance of receiving either the study drug (telitacicept) or placebo for 24 weeks of treatment. Both are taken as weekly injections, some of which may be self-injected at home between study visits. You can choose to do the injection at home or at our study site.
After the first 24-week treatment period is completed, you will have the option to take part in a 48-week extension treatment period where everyone will receive the study drug.
If you are interested in learning more, please email ResearchNCNE@neurocenterne.com / call 781-551-5812 opt.6.

This study is testing an investigational treatment for gMG to see if it may help muscles get the signals they need to work properly. Study treatments are given subcutaneously (by injection) once a week. Participants or a caregiver may receive training on how to use an autoinjector, which is an easy-to-use disposable syringe containing a single pre-measured dose of the study treatment.

Individuals may qualify for the study if they:

  • Are 18 to 80 years of age
  • Have been diagnosed with mild to severe generalized myasthenia gravis (gMG)
  • Are being treated or have been treated with one or more medication(s) for gMG
  • Meet additional study criteria

Whay does participation in the PROPEL study involve?

If you are eligible, your involvement may last yp to 87 weeks and may include up to 28 visits to the study site. Throughout your participation, you will be in close communication with the study team who will perform regular exams and lab tests to make sure you’re OK and to gather important information about your study treatment.

For more information about the study, and to see if you may qualify,

Please email ResearchNCNE@neurocenterne.com / call 781-551-5812 opt.6

Request Information

See if one of our Research Studies may be a good fit for you...


    Want to request an Appointment?

    Call us at 781-551-5812 or fill out the online appointment form...

    Accessibility Toolbar